Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment
about
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaEcto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity.Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.Pharmacogenomics in pediatric leukemia.Early gene expression of acute myeloid leukemia in response to chemotherapy.Pharmacogenetics of acute lymphoblastic leukemia treatment response.Genetic predispositions to childhood leukemia.Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine.Antileukemic drug effects in childhood acute lymphoblastic leukemia.Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.Methotrexate binds to recombinant thiopurine S-methyltransferase and inhibits enzyme activity after high-dose infusions in childhood leukaemia.Thiopurines induce oxidative stress in T-lymphocytes: a proteomic approach.Capturing changes in gene expression dynamics by gene set differential coordination analysis.Transporter-mediated protection against thiopurine-induced hematopoietic toxicityGene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia.
P2860
Q24685514-DB28CD1A-3636-42CD-97B3-81303BBCAE70Q28943431-1AAD3477-E087-4704-AF44-28F12DAC3D90Q34359524-BDD932CD-39D7-42E4-A06B-E046260845F6Q36402208-D31A12C4-25C7-420A-93B4-7B8058437C9FQ36727952-45F209E4-248D-44D1-970E-02C8BDF1DACAQ36817144-18962930-0CFF-4A06-825C-EE5F3413FBFFQ36968156-35E5D269-0420-4B23-946A-6F950B04A187Q37073895-BF045218-B927-4A98-849E-C3AEDA71820EQ37658863-402BF840-6BE1-4F9A-88BA-08EBCDDA59DCQ37724360-914E7EBF-EC2F-45AB-9D2D-FBE44D14B02BQ38178315-45B0A56E-300C-4BD6-B619-584343C0DD42Q38633437-E8F23F18-060C-491E-A871-2DBF8647DFD4Q39154080-61201938-16F8-4910-AE97-35A077CFB2DEQ39242293-2B8EA4F0-42E4-4E46-89B2-420EC2B14049Q39376365-096D1293-62CE-4BA3-9E99-83B8DBE2A8FBQ42222648-F637086B-D465-45A4-929C-886EC19E24E9Q50267725-0F93493F-02A3-4466-8CBF-375F670BFBB8
P2860
Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@ast
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@en
type
label
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@ast
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@en
prefLabel
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@ast
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@en
P2093
P2860
P1433
P1476
Gene expression and thioguanin ...... vivo mercaptopurine treatment
@en
P2093
Gianluigi Zaza
John C Panetta
Mary V Relling
Meyling Cheok
Wenjian Yang
William E Evans
P2860
P304
P356
10.1182/BLOOD-2005-01-0143
P407
P577
2005-05-19T00:00:00Z